US Patent Issued to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY on Dec. 9 for "Application of compound in treating pneumonia" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,180, issued on Dec. 9, was assigned to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY Co. LTD (Jiangsu, China).

"Application of compound in treating pneumonia" was invented by Xiawei Wei (Chengdu, China), Zhigang Huang (Shanghai), Charles Z. Ding (Shanghai) and Yuquan Wei (Chengdu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a use of a compound represented by formula (I) and a pharmaceutically acceptable salt thereof in the field of pharmaceutics, and in particular an application thereof in the preparation of a drug for treating pneumonia."

The patent was filed on Dec. 18, 2020, under Application No. 17/787,631.

*F...